MedPath

Near-Infrared Spectroscopy Comparison Study

Completed
Conditions
Total Aortic Arch Replacement
Registration Number
NCT01352260
Lead Sponsor
Nonin Medical, Inc
Brief Summary

The objective of this study is to validate Near-Infrared (NIRS) monitoring in patients undergoing circulatory arrest. This study will compare two-wavelength NIRS INVOS System, Somanetics; Troy, MI) with four-wavelength NIRS (Nonin Medical, Inc; Plymouth, MN) to determine which modality best correlates with jugular venous oxygen saturation

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  1. Provide written informed consent from patient or legally authorized representative before surgery
  2. Adult patients 18-65 years of age
  3. Presenting for elective or urgent total aortic arch repair under moderate hypothermic circulatory arrest (Nasopharyngeal temperature 20 - 24 ºC) with selective antegrade cerebral perfusion -
Exclusion Criteria
  1. Patients will be excluded from this study if they are age less than 18
  2. Are undergoing an emergent procedure
  3. Have a history of insulin-dependent diabetes mellitus
  4. Have a history of stroke
  5. Are undergoing a redo sternotomy during which major bleeding occurs necessitating transfusion of > 4 units of packed red blood cells prior to the institution of circulatory arrest
  6. Patients in whom a left jugular venous bulb cannula cannot successfully be placed

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Linear correlation between absolute value of cerebral oxygen saturation (rSO2) compared to Jugular Venous Oxygen Saturation (SjvO2). Sensitivity and specificity to detect < 60% desaturation.At the end of the surgical case approximately 6 to 8 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Baylor College of Medicine and affiliated Hospitals

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath